Introduction: Androgenetic alopecia (AGA) is a type of hair loss that often manifests as male or female pattern baldness. In women, AGA resembling male pattern baldness can occur in conditions of hyperandrogenism, such as congenital adrenal hyperplasia or ovarian and adrenal tumors, which are exceedingly rare, occurring in approximately 0.2% of cases. Case Presentation: We report a 62-year-old female exhibiting hair loss and hirsutism that began over a decade ago. The medical examination reveals hirsutism on the face, abdomen, and chest, and hair loss in the fronto-parieto-occipital region, with a male pattern distribution consistent with grade VII on the Hamilton scale. Trichoscopy revealed loss of follicular openings, single follicular units, miniaturized hairs, and perifollicular brown halo. Laboratory tests indicated a total testosterone level of 10.15 ng/mL. An abdominal CT scan revealed bilateral adrenal adenomas, which were subsequently treated with laparoscopic radical adrenalectomy. Conclusion: In postmenopausal women, a new-onset state of hyperandrogenism may lead to virilizing symptoms, such as male pattern alopecia, when testosterone levels exceed 5 nmol/L, necessitates immediate investigation to exclude an androgen-producing tumor, which typically normalizes swiftly within weeks post-surgery, while symptoms of androgen excess gradually diminish following the normalization of testosterone levels, as observed in our case. Identifying the cause of hyperandrogenism is crucial for treatment. Surgery remains the primary option for postmenopausal women with virilizing symptoms and androgen excess.

1.
Tawfik
C
,
Tejeda
CI
,
Haughton
AM
.
Case series evaluating the efficacy and safety of platelet-rich plasma for androgenetic alopecia in pediatric patients
.
JAAD Case Rep
.
2023
;
37
:
8
12
.
2.
Starace
M
,
Orlando
G
,
Alessandrini
A
,
Piraccini
BM
.
Female androgenetic alopecia: an update on diagnosis and management
.
Am J Clin Dermatol
.
2020
;
21
(
1
):
69
84
.
3.
Navea
C
,
Pavón
I
,
Guijarro
MG
,
Merino
M
.
Hiperandrogenismo secundario a tumor suprarrenal: causa rara a tener en cuenta
.
RIA
.
2015
;
13
(
4
):
142
5
.
4.
Martínez-Cornelio
A
,
Hernández-Toriz
N
,
Alvarado-Cabrero
I
,
Rodríguez
C
,
Ramos-Salgado
F
, et al
.
Mielolipoma suprarrenal, revisión de casos en México
.
Rev Mex Urol
.
2008
;
68
(
6
):
334
40
.
5.
Ebbehoj
A
,
Li
D
,
Kaur
RJ
,
Zhang
C
,
Singh
S
,
Li
T
, et al
.
Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study
.
Lancet Diabetes Endocrinol
.
2020
;
8
(
11
):
894
902
.
6.
Mendez Correa
GL
,
Chiluiza Villacis
KJ
,
Mejía Polo
AM
,
Guadalupe Montalvan
GF
.
Estudio del virilismo suprarrenal
.
Reciamuc
.
2022
;
6
(
2
):
252
60
.
7.
Hirschberg
AL
.
Approach to investigation of hyperandrogenism in a postmenopausal woman
.
JCEM
.
2023
;
108
(
5
):
1243
53
.
8.
Aljenaee
K
,
Ali
S
,
Cheah
SK
,
MacEneaney
O
,
Mulligan
N
,
Hickey
N
, et al
.
Marked hyperandrogenicity in a 60-year-old woman
.
Endocrinol Diabetes Metab Case Rep
.
2017
;
2017
:
17-0075
0075
.
9.
Yousaf
S
,
Nizar
R
,
John
L
,
Simpson
A
.
A case of ovarian hyperthecosis in a postmenopausal woman
.
JCEM Case Rep
.
2023
;
1
(
6
):
148
.
You do not currently have access to this content.